Trial Outcomes & Findings for Telemedicine To Provide Inflammatory Bowel Disease Outpatient Care (NCT NCT01296841)

NCT ID: NCT01296841

Last Updated: 2017-03-03

Results Overview

We used a validated Ware Specific Visit Questionnaire to assess patients' satisfaction with their clinic-visit encounter. This is a 14-item questionnaire on doctor-patient interaction including factors such as attention to complaints, technical skills, and personal manner (courtesy,and ease of appointment scheduling and is based on a five-point Likert scale (1 excellent to 5 poor). Patients completed the questionnaire at the time of the visit. The 14 item scores were individually scored and then averaged to provide the final overall value.

Recruitment status

COMPLETED

Study phase

PHASE2

Target enrollment

34 participants

Primary outcome timeframe

Clinic Visit

Results posted on

2017-03-03

Participant Flow

Participant milestones

Participant milestones
Measure
Standard Encounter
Standard "in-house" clinical visit between patient and physician.
Telemedicine Encounter
Remote clinical appointment between patient and physician.
Overall Study
STARTED
19
15
Overall Study
COMPLETED
19
15
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Telemedicine To Provide Inflammatory Bowel Disease Outpatient Care

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Standard Encounter
n=19 Participants
Standard "in-house" clinical visit between patient and physician.
Telemedicine Encounter
n=15 Participants
Remote clinical appointment between patient and physician.
Total
n=34 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Age, Categorical
Between 18 and 65 years
15 Participants
n=99 Participants
9 Participants
n=107 Participants
24 Participants
n=206 Participants
Age, Categorical
>=65 years
4 Participants
n=99 Participants
6 Participants
n=107 Participants
10 Participants
n=206 Participants
Age, Continuous
58.5 years
STANDARD_DEVIATION 9.6 • n=99 Participants
62.8 years
STANDARD_DEVIATION 11.5 • n=107 Participants
60.4 years
STANDARD_DEVIATION 10.5 • n=206 Participants
Gender
Female
6 Participants
n=99 Participants
2 Participants
n=107 Participants
8 Participants
n=206 Participants
Gender
Male
13 Participants
n=99 Participants
13 Participants
n=107 Participants
26 Participants
n=206 Participants
Region of Enrollment
United States
19 participants
n=99 Participants
15 participants
n=107 Participants
34 participants
n=206 Participants

PRIMARY outcome

Timeframe: Clinic Visit

Population: per protocol

We used a validated Ware Specific Visit Questionnaire to assess patients' satisfaction with their clinic-visit encounter. This is a 14-item questionnaire on doctor-patient interaction including factors such as attention to complaints, technical skills, and personal manner (courtesy,and ease of appointment scheduling and is based on a five-point Likert scale (1 excellent to 5 poor). Patients completed the questionnaire at the time of the visit. The 14 item scores were individually scored and then averaged to provide the final overall value.

Outcome measures

Outcome measures
Measure
Telemedicine
n=15 Participants
clinic experience (mean ± SD, 1 excellent, 5 poor)
Standard
n=19 Participants
clinic experience (mean±SD)
Patient Clinical Experience
1.2 units on a scale
Standard Deviation 0.4
1.3 units on a scale
Standard Deviation 0.5

SECONDARY outcome

Timeframe: Clinic Visit

Population: Pilot.

The investigators recorded appointment duration in minutes.

Outcome measures

Outcome measures
Measure
Telemedicine
n=19 Participants
clinic experience (mean ± SD, 1 excellent, 5 poor)
Standard
n=15 Participants
clinic experience (mean±SD)
Clinic Appointment Duration
59 Minutes
Standard Deviation 18
60 Minutes
Standard Deviation 25

SECONDARY outcome

Timeframe: Clinic Visit

The investigators recorded clinic appointment wait time duration in minutes

Outcome measures

Outcome measures
Measure
Telemedicine
n=19 Participants
clinic experience (mean ± SD, 1 excellent, 5 poor)
Standard
n=15 Participants
clinic experience (mean±SD)
Clinic Appointment Wait Time
18 minutes
Standard Deviation 14.5
25 minutes
Standard Deviation 25

Adverse Events

Standard Encounter

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Telemedicine Encounter

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Roy Soetikno

VA Palo Alto

Phone: 650-493-5000

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place